Bone Therapeutics Completes Recruitment in ALLOB Phase IIA Spinal Fusion Study
Bone Therapeutics completed recruitment for its ALLOB® allogeneic cell therapy Phase IIA spinal fusion study. The company will extend the trial to assess early onset of bone formation and fusion. May 03, 2016